Walleye Trading’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Walleye Trading’s Portfolio BLACR Stock Details BLACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-236,430	Closed	-$30.7K	–	4889
2024 Q4	$30.7K	Buy	236,430 +141,858	+150%	+$17.8K	﹤0.01%	3881
2024 Q3	$10.3K	Hold	94,572	–	–	﹤0.01%	3757
2024 Q2	$9.46K	Hold	94,572	–	–	﹤0.01%	3882
2024 Q1	$14.2K	Hold	94,572	–	–	﹤0.01%	4258
2023 Q4	$14.2K	Buy	+94,572	New	+$15.3K	﹤0.01%	4557

Walleye Trading's BLACR Position: Q1 2025 in Review

Walleye Trading sold out of Bellevue Life Sciences Acquisition Corp. Rights (BLACR) in Q1 2025, closing a stake of 236,430 shares — an estimated $30.7K sold.

Walleye Trading first reported a position in BLACR in Q4 2023 and held it in 5 quarters. The position peaked at $30.7K in Q4 2024. 0 funds tracked by Wall St. Rank hold BLACR as of Q1 2025.

Walleye Trading reported no remaining Bellevue Life Sciences Acquisition Corp. Rights position as of Q1 2025 after selling out during the quarter.
Walleye Trading sold 236,430 Bellevue Life Sciences Acquisition Corp. Rights shares in Q1 2025, an estimated $30.7K.
Walleye Trading first reported a position in Bellevue Life Sciences Acquisition Corp. Rights in Q4 2023 and held it in 5 quarters.
Walleye Trading's Bellevue Life Sciences Acquisition Corp. Rights position peaked at $30.7K in Q4 2024.
0 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Rights as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.